+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Biology"

Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
Anti-Cancer MAbS Global Market Report 2024 - Product Thumbnail Image

Anti-Cancer MAbS Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Perspectives in Lung Cancer - Product Thumbnail Image

Perspectives in Lung Cancer

  • Book
  • July 2020
From
From
Loading Indicator

The Cancer Biology market within the context of Oncology is a rapidly growing field of research and development. It focuses on the study of the biological processes that cause cancer, as well as the development of treatments and therapies to combat the disease. This includes the study of the genetic and molecular basis of cancer, the development of targeted therapies, and the use of biomarkers to diagnose and monitor the disease. Additionally, the field of cancer biology is also involved in the development of new technologies and treatments to improve the quality of life for cancer patients. The Cancer Biology market is a highly competitive field, with many companies and organizations competing to develop the most effective treatments and therapies. Some of the major players in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Additionally, there are many smaller companies and research organizations that are actively involved in the development of new treatments and therapies for cancer. Show Less Read more